Actualités
-
“Heart Valve Disease: A Genetic and Biological Odyssey” Invited by Nabila BOUATIA-NAJI
-
“Cyclophilin A, a novel target in cardiovascular disease: roles in redox signaling and inflammation” Invited by Alain Tedgui
-
“Targeting the microbial pharmacists within us to lower blood pressure” Invited by Rachel Climie
-
L’indoléamine 2, 3-dioxygénase (IDO) est une enzyme surexprimée chez les personnes atteintes d’obésité, de diabète ou encore d’hypercholestérolémie. Une série d’expériences menées chez la souris indique que son activité, associée à un microbiote intestinal particulier, serait directement responsable de l’apparition de ces troubles. article entier
-
“Sofinnova Partners: historique, présentation générale et stratégie d’investissement”
-
Pr. Loupy was awarded in 2018 by the French National Academy of Medicine for his work in kidney transplantation, graft rejection by anti-HLA Donor Specific Antibodies and biomarker discovery. More details here
-
“Skeletal muscle energetics and exercise intolerance in heart failure: maybe more than the heart is failing?” Invited by Bertrand Tavitian